Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180


External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules.

Baldwin DR, Gustafson J, Pickup L, Arteta C, Novotny P, Declerck J, Kadir T, Figueiras C, Sterba A, Exell A, Potesil V, Holland P, Spence H, Clubley A, O'Dowd E, Clark M, Ashford-Turner V, Callister ME, Gleeson FV.

Thorax. 2020 Mar 5. pii: thoraxjnl-2019-214104. doi: 10.1136/thoraxjnl-2019-214104. [Epub ahead of print]


Intercostal vessel screening prior to pleural interventions by the respiratory physician - a prospective study of real world practice.

Bedawi EO, Talwar A, Hassan M, McCracken DJ, Asciak R, Mercer RM, Kanellakis NI, Gleeson FV, Hallifax RJ, Wrightson JM, Rahman NM.

Eur Respir J. 2020 Mar 5. pii: 1902245. doi: 10.1183/13993003.02245-2019. [Epub ahead of print]


Effect of 18F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial.

Scarsbrook AF, Bottomley D, Teoh EJ, Bradley KM, Payne H, Afaq A, Bomanji J, van As N, Chua S, Hoskin P, Chambers A, Cook GJ, Warbey VS, Han S, Leung HY, Chau A, Miller MP, Gleeson FV; FALCON study group.

Int J Radiat Oncol Biol Phys. 2020 Feb 14. pii: S0360-3016(20)30203-0. doi: 10.1016/j.ijrobp.2020.01.050. [Epub ahead of print]


Negotiating the risks of computed tomography in primary care.

Moreland JA, Gleeson FV, Nicholson BD.

Br J Gen Pract. 2020 Jan 30;70(691):86-87. doi: 10.3399/bjgp20X708029. Print 2020 Feb. No abstract available.


Thoracic ultrasound competence for ultrasound-guided pleural procedures.

McCracken DJ, Laursen CB, Barker G, Gleeson FV, Cullen KM, Rahman NM.

Eur Respir Rev. 2019 Dec 23;28(154). pii: 190090. doi: 10.1183/16000617.0090-2019. Print 2019 Dec 31. Review.


CT-based Airway Flow Model to Assess Ventilation in Chronic Obstructive Pulmonary Disease: A Pilot Study.

Kim M, Doganay O, Matin TN, Povey T, Gleeson FV.

Radiology. 2019 Dec;293(3):666-673. doi: 10.1148/radiol.2019190395. Epub 2019 Oct 15.


18Fluorocholine PET/CT scanning with arterial phase-enhanced CT is useful for persistent/recurrent primary hyperparathyroidism: first UK case series results.

Christakis I, Khan S, Sadler GP, Gleeson FV, Bradley KM, Mihai R.

Ann R Coll Surg Engl. 2019 Sep;101(7):501-507. doi: 10.1308/rcsann.2019.0059. Epub 2019 Jul 15.


Patch-based lung ventilation estimation using multi-layer supervoxels.

Szmul A, Matin T, Gleeson FV, Schnabel JA, Grau V, Papież BW.

Comput Med Imaging Graph. 2019 Jun;74:49-60. doi: 10.1016/j.compmedimag.2019.04.002. Epub 2019 Apr 5.


Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma.

McGowan DR, Skwarski M, Bradley KM, Campo L, Fenwick JD, Gleeson FV, Green M, Horne A, Maughan TS, McCole MG, Mohammed S, Muschel RJ, Ng SM, Panakis N, Prevo R, Strauss VY, Stuart R, Tacconi EMC, Vallis KA, McKenna WG, Macpherson RE, Higgins GS.

Eur J Cancer. 2019 May;113:87-95. doi: 10.1016/j.ejca.2019.03.015. Epub 2019 Apr 13.


Is microwave ablation more effective than radiofrequency ablation in achieving local control for primary pulmonary malignancy?

Tsakok MT, Jones D, MacNeill A, Gleeson FV.

Interact Cardiovasc Thorac Surg. 2019 Mar 30. pii: ivz044. doi: 10.1093/icvts/ivz044. [Epub ahead of print]


Factors predicting ablation site recurrence following percutaneous microwave ablation of colorectal hepatic metastases.

Urbonas T, Anderson EM, Gordon-Weeks AN, Kabir SI, Soonawalla Z, Silva MA, Gleeson FV, Reddy S.

HPB (Oxford). 2019 Sep;21(9):1175-1184. doi: 10.1016/j.hpb.2019.01.007. Epub 2019 Feb 16.


Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial.

Gray MD, Lyon PC, Mannaris C, Folkes LK, Stratford M, Campo L, Chung DYF, Scott S, Anderson M, Goldin R, Carlisle R, Wu F, Middleton MR, Gleeson FV, Coussios CC.

Radiology. 2019 Apr;291(1):232-238. doi: 10.1148/radiol.2018181445. Epub 2019 Jan 15.


Time-series hyperpolarized xenon-129 MRI of lobar lung ventilation of COPD in comparison to V/Q-SPECT/CT and CT.

Doganay O, Matin T, Chen M, Kim M, McIntyre A, McGowan DR, Bradley KM, Povey T, Gleeson FV.

Eur Radiol. 2019 Aug;29(8):4058-4067. doi: 10.1007/s00330-018-5888-y. Epub 2018 Dec 14.


Magnetic resonance imaging of the time course of hyperpolarized 129Xe gas exchange in the human lungs and heart.

Doganay O, Chen M, Matin T, Rigolli M, Phillips JA, McIntyre A, Gleeson FV.

Eur Radiol. 2019 May;29(5):2283-2292. doi: 10.1007/s00330-018-5853-9. Epub 2018 Dec 5.


Local control, safety, and survival following image-guided percutaneous microwave thermal ablation in primary lung malignancy.

Tsakok MT, Little MW, Hynes G, Millington RS, Boardman P, Gleeson FV, Anderson EM.

Clin Radiol. 2019 Jan;74(1):80.e19-80.e26. doi: 10.1016/j.crad.2018.09.014. Epub 2018 Nov 14.


Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study.

Bryant RJ, Hobbs CP, Eyre KS, Davies LC, Sullivan ME, Shields W, Sooriakumaran P, Verrill CL, Gleeson FV, MacPherson RE, Hamdy FC, Brewster SF.

J Urol. 2019 Mar;201(3):510-519. doi: 10.1016/j.juro.2018.09.049.


Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer.

Lyon PC, Winter H, Herbschleb K, Campo L, Carlisle R, Wu F, Goldin R, Coussios CC, Middleton MR, Gleeson FV, Boardman P, Sharma RA.

Radiol Case Rep. 2018 Sep 22;13(6):1259-1266. doi: 10.1016/j.radcr.2018.08.020. eCollection 2018 Dec.


Whole tumor kinetics analysis of 18F-fluoromisonidazole dynamic PET scans of non-small cell lung cancer patients, and correlations with perfusion CT blood flow.

McGowan DR, Skwarski M, Papiez BW, Macpherson RE, Gleeson FV, Schnabel JA, Higgins GS, Fenwick JD.

EJNMMI Res. 2018 Aug 1;8(1):73. doi: 10.1186/s13550-018-0430-4.


Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial.

Lyon PC, Gray MD, Mannaris C, Folkes LK, Stratford M, Campo L, Chung DYF, Scott S, Anderson M, Goldin R, Carlisle R, Wu F, Middleton MR, Gleeson FV, Coussios CC.

Lancet Oncol. 2018 Aug;19(8):1027-1039. doi: 10.1016/S1470-2045(18)30332-2. Epub 2018 Jul 11.


Embrace Progress.

Bradley KM, McGowan DR, Gleeson FV, Johnson GB, Young JR, Levin CS, Davidzon GA, Iagaru AH.

J Nucl Med. 2018 Jul;59(7):1169. doi: 10.2967/jnumed.118.212761. Epub 2018 Apr 26. No abstract available.


GIFTed Demons: deformable image registration with local structure-preserving regularization using supervoxels for liver applications.

Papież BW, Franklin JM, Heinrich MP, Gleeson FV, Brady M, Schnabel JA.

J Med Imaging (Bellingham). 2018 Apr;5(2):024001. doi: 10.1117/1.JMI.5.2.024001. Epub 2018 Apr 4.


Lung abscess or empyema? Taking a closer look.

Hassan M, Asciak R, Rizk R, Shaarawy H, Gleeson FV, Rahman NM.

Thorax. 2018 Sep;73(9):887-889. doi: 10.1136/thoraxjnl-2018-211604. Epub 2018 Mar 26. No abstract available.


Pulmonary nodules: Assessing the imaging biomarkers of malignancy in a "coffee-break".

Talwar A, Willaime JMY, Pickup LC, Enescu M, Boukerroui D, Hickes W, Rahman NM, Gooding MJ, Kadir T, Gleeson FV.

Eur J Radiol. 2018 Apr;101:82-86. doi: 10.1016/j.ejrad.2018.02.004. Epub 2018 Feb 7.


Abstracts of the 33rd International Austrian Winter Symposium : Zell am See, Austria. 24-27 January 2018.

Binzel K, Adelaja A, Wright CL, Scharre D, Zhang J, Knopp MV, Teoh EJ, Bottomley D, Scarsbrook A, Payne H, Afaq A, Bomanji J, van As N, Chua S, Hoskin P, Chambers A, Cook GJ, Warbey VS, Chau A, Ward P, Miller MP, Stevens DJ, Wilson L, Gleeson FV, Scheidhauer K, Seidl C, Autenrieth M, Bruchertseifer F, Apostolidis C, Kurtz F, Horn T, Pfob C, Schwaiger M, Gschwend J, D'Alessandria C, Morgenstern A, Uprimny C, Kroiss A, Decristoforo C, von Guggenberg E, Nilica B, Horninger W, Virgolini I, Rasul S, Poetsch N, Woehrer A, Preusser M, Mitterhauser M, Wadsak W, Widhalm G, Mischkulnig M, Hacker M, Traub-Weidinger T, Wright CL, Binzel K, Wuthrick EJ, Miller ED, Maniawski P, Zhang J, Knopp MV, Rep S, Hocevar M, Vaupotic J, Zdesar U, Zaletel K, Lezaic L, Mairinger S, Filip T, Sauberer M, Flunkert S, Wanek T, Stanek J, Okamura N, Langer O, Kuntner C, Fornito MC, Balzano R, Di Martino V, Cacciaguerra S, Russo G, Seifert D, Kleinova M, Cepa A, Ralis J, Hanc P, Lebeda O, Mosa M, Vandenberghe S, Mikhaylova E, Borys D, Viswanath V, Stockhoff M, Efthimiou N, Caribe P, Van Holen R, Karp JS, Binzel K, Zhang J, Wright CL, Maniawski P, Knopp MV, Haller PM, Farhan C, Piackova E, Jäger B, Knoll P, Kiss A, Podesser BK, Wojta J, Huber K, Mirzaei S, Traxl A, Komposch K, Glitzner E, Wanek T, Mairinger S, Sibilia M, Langer O, Fornito MC, Russello M, Russo G, Balzano R, Sorko S, Gallowitsch HJ, Kohlfuerst S, Matschnig S, Rieser M, Sorschag M, Lind P, Ležaič L, Rep S, Žibert J, Frelih N, Šuštar S, Binzel K, Adelaja A, Wright CL, Scharre D, Zhang J, Knopp MV, Baum RP, Langbein T, Singh A, Shahinfar M, Schuchardt C, Volk GF, Kulkarni HR, Fornito MC, Cacciaguerra S, Balzano R, Di Martino GV, Russo G, Thomson WH, Kudlacek M, Karik M, Farhan C, Rieger H, Pokieser W, Glaser K, Mirzaei S, Petz V, Tugendsam C, Buchinger W, Schmoll-Hauer B, Schenk IP, Rudolph K, Krebs M, Zettinig G, Zoufal V, Wanek T, Krohn M, Mairinger S, Stanek J, Sauberer M, Filip T, Pahnke J, Langer O, Weitzer F, Pernthaler B, Salamon S, Aigner R, Koranda P, Henzlová L, Kamínek M, Váchalová M, Bachleda P, Summer D, Garousi J, Oroujeni M, Mitran B, Andersson KG, Vorobyeva A, Löfblom JN, Orlova A, Tolmachev V, Decristoforo C, Kaeopookum P, Summer D, Orasch T, Lechner B, Petrik M, Novy Z, Rangger C, Haas H, Decristoforo C.

EJNMMI Res. 2018 Jan 23;8(Suppl 1):5. doi: 10.1186/s13550-017-0354-4. No abstract available.


Bayesian penalised likelihood reconstruction (Q.Clear) of 18F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation.

Teoh EJ, McGowan DR, Schuster DM, Tsakok MT, Gleeson FV, Bradley KM.

Br J Radiol. 2018 May;91(1085):20170727. doi: 10.1259/bjr.20170727. Epub 2018 Jan 22.


Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours.

Lyon PC, Griffiths LF, Lee J, Chung D, Carlisle R, Wu F, Middleton MR, Gleeson FV, Coussios CC.

J Ther Ultrasound. 2017 Nov 2;5:28. doi: 10.1186/s40349-017-0104-0. eCollection 2017.


Fast dynamic ventilation MRI of hyperpolarized 129 Xe using spiral imaging.

Doganay O, Matin TN, Mcintyre A, Burns B, Schulte RF, Gleeson FV, Bulte D.

Magn Reson Med. 2018 May;79(5):2597-2606. doi: 10.1002/mrm.26912. Epub 2017 Sep 16.


Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer.

Teoh EJ, Tsakok MT, Bradley KM, Hyde K, Subesinghe M, Gleeson FV.

Clin Nucl Med. 2017 Oct;42(10):803-804. doi: 10.1097/RLU.0000000000001789.


18 F-fluoromisonidazole uptake in advanced stage non-small cell lung cancer: A voxel-by-voxel PET kinetics study.

McGowan DR, Macpherson RE, Hackett SL, Liu D, Gleeson FV, McKenna WG, Higgins GS, Fenwick JD.

Med Phys. 2017 Sep;44(9):4665-4676. doi: 10.1002/mp.12416. Epub 2017 Jul 21.


Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab.

Patel N, Able S, Allen D, Fokas E, Cornelissen B, Gleeson FV, Harris AL, Vallis KA.

EJNMMI Res. 2017 Dec;7(1):49. doi: 10.1186/s13550-017-0297-9. Epub 2017 May 30.


Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.

Findlay JM, Bradley KM, Wang LM, Franklin JM, Teoh EJ, Gleeson FV, Maynard ND, Gillies RS, Middleton MR.

Br J Surg. 2017 Jun;104(7):947. doi: 10.1002/bjs.10611. No abstract available.


State-of-the-art: Radiological investigation of pleural disease.

Hallifax RJ, Talwar A, Wrightson JM, Edey A, Gleeson FV.

Respir Med. 2017 Mar;124:88-99. doi: 10.1016/j.rmed.2017.02.013. Epub 2017 Feb 17. Review.


Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.

Findlay JM, Bradley KM, Wang LM, Franklin JM, Teoh EJ, Gleeson FV, Maynard ND, Gillies RS, Middleton MR.

Br J Surg. 2017 Mar;104(4):408-417. doi: 10.1002/bjs.10435. Epub 2017 Jan 17. Erratum in: Br J Surg. 2017 Jun;104(7):947.


Accuracy and cost-effectiveness of dynamic contrast-enhanced CT in the characterisation of solitary pulmonary nodules-the SPUtNIk study.

Qureshi NR, Rintoul RC, Miles KA, George S, Harris S, Madden J, Cozens K, Little LA, Eichhorst K, Jones J, Moate P, McClement C, Pike L, Sinclair D, Wong WL, Shekhdar J, Eaton R, Shah A, Brindle L, Peebles C, Banerjee A, Dizdarevic S, Han S, Poon FW, Groves AM, Kurban L, Frew AJ, Callister ME, Crosbie P, Gleeson FV, Karunasaagarar K, Kankam O, Gilbert FJ.

BMJ Open Respir Res. 2016 Oct 14;3(1):e000156. eCollection 2016.


Software Respiratory Gating of Positron Emission Tomography-Computed Tomography Improves Pulmonary Nodule Detection.

Morley NC, McGowan DR, Gleeson FV, Bradley KM.

Am J Respir Crit Care Med. 2017 Jan 15;195(2):261-262. doi: 10.1164/rccm.201607-1371IM. No abstract available.


Chronic Obstructive Pulmonary Disease: Lobar Analysis with Hyperpolarized 129Xe MR Imaging.

Matin TN, Rahman N, Nickol AH, Chen M, Xu X, Stewart NJ, Doel T, Grau V, Wild JM, Gleeson FV.

Radiology. 2017 Mar;282(3):857-868. doi: 10.1148/radiol.2016152299. Epub 2016 Oct 12.


Large airways nodularity secondary to tracheobronchopathia osteochondroplastica.

Corcoran JP, Wrightson JM, Moore AJ, Gleeson FV, Sykes A.

Thorax. 2017 Mar;72(3):288-289. doi: 10.1136/thoraxjnl-2016-209164. Epub 2016 Sep 28. No abstract available.


Predicting Pathologic Response of Esophageal Cancer to Neoadjuvant Chemotherapy: The Implications of Metabolic Nodal Response for Personalized Therapy.

Findlay JM, Bradley KM, Wang LM, Franklin JM, Teoh EJ, Gleeson FV, Maynard ND, Gillies RS, Middleton MR.

J Nucl Med. 2017 Feb;58(2):266-275. doi: 10.2967/jnumed.116.176313. Epub 2016 Sep 15. Erratum in: J Nucl Med. 2017 May;58(5):852.


Imaging oligometastatic cancer before local treatment.

Franklin JM, Sharma RA, Harris AL, Gleeson FV.

Lancet Oncol. 2016 Sep;17(9):e406-14. doi: 10.1016/S1470-2045(16)30277-7. Epub 2016 Aug 30. Review.


Does perfusion CT play a role in the evaluation of percutaneous microwave-ablated lung tumours?

Parvizi N, Chung D, Little MW, Gleeson FV, Anderson EM.

Clin Radiol. 2016 Nov;71(11):1137-42. doi: 10.1016/j.crad.2016.07.005. Epub 2016 Aug 21.


Pieces-of-parts for supervoxel segmentation with global context: Application to DCE-MRI tumour delineation.

Irving B, Franklin JM, Papież BW, Anderson EM, Sharma RA, Gleeson FV, Brady SM, Schnabel JA.

Med Image Anal. 2016 Aug;32:69-83. doi: 10.1016/ Epub 2016 Mar 21.


18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstruction.

Teoh EJ, McGowan DR, Bradley KM, Belcher E, Black E, Moore A, Sykes A, Gleeson FV.

Eur Radiol. 2016 Nov;26(11):4098-4106. Epub 2016 Feb 25.


Restaging oesophageal cancer after neoadjuvant therapy with (18)F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgery.

Findlay JM, Gillies RS, Franklin JM, Teoh EJ, Jones GE, di Carlo S, Gleeson FV, Maynard ND, Bradley KM, Middleton MR.

Eur Radiol. 2016 Oct;26(10):3519-33. doi: 10.1007/s00330-016-4227-4. Epub 2016 Feb 16.


Return of the pulmonary nodule: the radiologist's key role in implementing the 2015 BTS guidelines on the investigation and management of pulmonary nodules.

Graham RN, Baldwin DR, Callister ME, Gleeson FV.

Br J Radiol. 2016;89(1059):20150776. doi: 10.1259/bjr.20150776. Epub 2016 Jan 19.


Diagnostic value of radiological imaging pre- and post-drainage of pleural effusions.

Corcoran JP, Acton L, Ahmed A, Hallifax RJ, Psallidas I, Wrightson JM, Rahman NM, Gleeson FV.

Respirology. 2016 Feb;21(2):392-5. doi: 10.1111/resp.12675. Epub 2015 Nov 6.


Multicenter Reproducibility of 18F-Fluciclatide PET Imaging in Subjects with Solid Tumors.

Sharma R, Kallur KG, Ryu JS, Parameswaran RV, Lindman H, Avril N, Gleeson FV, Lee JD, Lee KH, O'Doherty MJ, Groves AM, Miller MP, Somer EJ, Coombes CR, Aboagye EO.

J Nucl Med. 2015 Dec;56(12):1855-61. doi: 10.2967/jnumed.115.158253. Epub 2015 Sep 17.


18F-Misonidazole PET-CT scan detection of occult bone metastasis.

McGowan DR, Macpherson RE, Bradley KM, Fenwick JD, Gleeson FV, Higgins GS.

Thorax. 2016 Jan;71(1):97. doi: 10.1136/thoraxjnl-2015-207400. Epub 2015 Sep 8. No abstract available.


Absence of Atypical Pathogens in Pleural Infection.

Wrightson JM, Wray JA, Street TL, Chapman SJ, Gleeson FV, Maskell NA, Peto TEA, Rahman NM, Crook DWM.

Chest. 2015 Sep;148(3):e102-e103. doi: 10.1378/chest.15-1130. No abstract available.


Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?

Parvizi N, Franklin JM, McGowan DR, Teoh EJ, Bradley KM, Gleeson FV.

Eur J Radiol. 2015 Oct;84(10):1873-8. doi: 10.1016/j.ejrad.2015.06.025. Epub 2015 Jun 29.


Phantom and Clinical Evaluation of the Bayesian Penalized Likelihood Reconstruction Algorithm Q.Clear on an LYSO PET/CT System.

Teoh EJ, McGowan DR, Macpherson RE, Bradley KM, Gleeson FV.

J Nucl Med. 2015 Sep;56(9):1447-52. doi: 10.2967/jnumed.115.159301. Epub 2015 Jul 9.

Supplemental Content

Loading ...
Support Center